Strengthening Gastric Cancer Therapy by Trastuzumab-Conjugated Nanoparticles with Simultaneous Encapsulation of Anti-MiR-21 and 5-Fluorouridine

MLA

Nan Hu, et al. “Strengthening Gastric Cancer Therapy by Trastuzumab-Conjugated Nanoparticles with Simultaneous Encapsulation of Anti-MiR-21 and 5-Fluorouridine.” Cellular Physiology and Biochemistry, vol. 44, no. 6, Dec. 2017, pp. 2158–73. EBSCOhost, https://doi.org/10.1159/000485955.

APA

Nan Hu, Jun Feng Yin, Ze Ji, Yidong Hong, Puyuan Wu, Baoxiang Bian, Ziyan Song, Rutian Li, Qin Liu, & Fenglei Wu. (2017). Strengthening Gastric Cancer Therapy by Trastuzumab-Conjugated Nanoparticles with Simultaneous Encapsulation of Anti-MiR-21 and 5-Fluorouridine. Cellular Physiology and Biochemistry, 44(6), 2158–2173. https://doi.org/10.1159/000485955

Chicago

Nan Hu, Jun Feng Yin, Ze Ji, Yidong Hong, Puyuan Wu, Baoxiang Bian, Ziyan Song, Rutian Li, Qin Liu, and Fenglei Wu. 2017. “Strengthening Gastric Cancer Therapy by Trastuzumab-Conjugated Nanoparticles with Simultaneous Encapsulation of Anti-MiR-21 and 5-Fluorouridine.” Cellular Physiology and Biochemistry 44 (6): 2158–73. doi:10.1159/000485955.